Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

AI-Generated Synthetic Patient Data Helps in Evaluating Daratumumab Treatment Benefit in Multiple Myeloma Subgroups

Merav Bar, Andrew J. Cowan, Qian Shi, Zixuan Zhao, Zexin Ren, Feifang Hu, Will Ma

Blood (2024) 144 (Supplement 1): 7491.

https://doi.org/10.1182/blood-2024-208174

Published: 2024

Journal Articles

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

Blood (2024) 144 (10): 1069–1082.

https://doi.org/10.1182/blood.2024024105

Published: 2024

Includes: Supplemental data

Journal Articles

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Blood (2023) 142 (Supplement 1): 475.

https://doi.org/10.1182/blood-2023-188032

Published: 2023

Journal Articles

Neutrophil Activation Is a Diagnostic and Candidate Prognostic Biomarker of Acute GvHD

Mohammed El Anbari, Merav Bar, Mohammed Toufiq, Darawan Rinchai, Dhanya Kizhakayil, Irene Cavattoni, Nikolett Lupsa, Phuong T Vo, Sara Tomei, Ayman Saleh, Chiara Cugno, Annalisa Terranegra, Zoltan Pos, Damien Chaussabel, Sara Deola

Blood (2023) 142 (Supplement 1): 2186.

https://doi.org/10.1182/blood-2023-174486

Published: 2023

Journal Articles

MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Blood (2021) 138 (Supplement 1): 2955.

https://doi.org/10.1182/blood-2021-149313

Published: 2021

Journal Articles

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Blood (2021) 137 (3): 323–335.

https://doi.org/10.1182/blood.2020006770

Published: 2021

Includes: Supplemental data

Journal Articles

Patient-Reported Outcomes at Time of CAR-T Cell Therapy

Erin Mullane, Taylor Jones, Jenna Voutsinas, MPH, Qian Vicky Wu, PhD, Elizabeth Loggers, MD PhD, Jesse Fann, David G. Maloney, MD PhD, Merav Bar

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-134646

Published: 2020

Journal Articles

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8 + and CD4 + Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

Elizabeth F Krakow, MDMSc, Corinne Summers, MD, Ann Dahlberg, MD, Merav Bar, Melinda Ann Biernacki, Tanya Cunningham, MSc, Nicole Vartanian, MSc, Megan Hickner, RN, Colette Chaney, RN, Tsadik Habtetsion, PhD, Kyle Woodward, PhD, Robson Dossa, PhD, Michelle Brault, PhD, Marie Bleakley, MBBS MMSc PhD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-137726

Published: 2020

Journal Articles

Pre-Transplant Gene Expression May Predict Risk of Graft Versus Host Disease

Merav Bar, Darawan Rinchai, Mohammed Toufiq, Mohammed Elanbari, Dhanya Kizhakayil, Harshitha Shobha Manjunath, Rebecca Mathew, Irene M Cavattoni, Sabine Forer, Clarisa Brown, Nancy Miles, Sara Tomei, Chiara Cugno, MD, Damien Chaussabel, Sara Deola

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-142840

Published: 2020

Journal Articles

Third Generation CD20 Targeted CAR T-Cell Therapy (MB-106) for Treatment of Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-136440

Published: 2020

Journal Articles

Mapping the Road of Gvhd and GVT: A Longitudinal Study of Immune-Transcriptome Signatures As Novel Approach to Solve Post-Allogeneic Hematopoietic Cell Transplantation Dilemmas

Merav Bar, MD, Alice Woo, Mohammed Toufiq, Sabri Boughorbel, Darawan Rinchai, Mohammed Elanbari, Valentina Mattei, Rebecca Mathew, Irene Cavattoni, MD, Sabine Forer, Marco Zecca, Patrizia Comoli, Giovanni Grillo, MD, Catherine Cole, Chiara Cugno, MD, Sara Tomei, PhD, Damien Chaussabel, Sara Deola

Blood (2019) 134 (Supplement_1): 4550.

https://doi.org/10.1182/blood-2019-122884

Published: 2019

Journal Articles

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy

Merav Bar, MD, Julia Ruark, MD MPH, Erin Mullane, DNP, Nancy Cleary, BSc, Ana Cordeiro, MD, Evandro D. Bezerra, MD, Jenna M. Voutsinas, MPH, Bronwen E. Shaw, MD PhD, Qian Vicky Wu, PhD, Kathryn E Flynn, PhD, Stephanie J. Lee, MD MPH, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Jesse Fann

Blood (2019) 134 (Supplement_1): 4453.

https://doi.org/10.1182/blood-2019-122755

Published: 2019

Journal Articles

Severe Cytokine Release Syndrome Is Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy

Krishna R. Juluri, MD PhD, Alexandre V. Hirayama, MD, Erin Mullane, DNP, Nancy Cleary, BSc, Qian Vicky Wu, PhD, David G. Maloney, MD PhD, Cameron J. Turtle, MBBS, PhD, Merav Bar, MD, Jordan Gauthier, MD MSc

Blood (2019) 134 (Supplement_1): 3229.

https://doi.org/10.1182/blood-2019-126922

Published: 2019

Journal Articles

Late Effects of CD19-Targeted CAR-T Cell Therapy

Ana Cordeiro, Evandro D Bezerra, Joshua Aiden Hill, MD, Cameron J. Turtle, MBBS, PhD, David G. Maloney, MD PhD, Merav Bar, MD

Blood (2018) 132 (Supplement 1): 223.

https://doi.org/10.1182/blood-2018-99-112023

Published: 2018

Journal Articles

EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML

Blood (2016) 128 (22): 1001.

https://doi.org/10.1182/blood.V128.22.1001.1001

Published: 2016

Journal Articles

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Blood (2016) 128 (22): 985.

https://doi.org/10.1182/blood.V128.22.985.985

Published: 2016

Journal Articles

Reversal of Low Donor Chimerism Following Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion

Merav Bar, MD, Mary Flowers, MD, Barry E. Storer, PhD, Thomas R. Chauncey, MD PhD, Michael A Pulsipher, MD, Monica S Thakar, MD, Wolfgang Bethge, MD, Rainer F. Storb, MD, David G Maloney, Brenda M. Sandmaier, MD

Blood (2016) 128 (22): 2215.

https://doi.org/10.1182/blood.V128.22.2215.2215

Published: 2016

Journal Articles

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Merav Bar, MD, Aude G. Chapuis, MD, Thomas M Schmitt, PhD, Hieu Nguyen, Natalie A Duerkopp, Mark F Tom, Felecia D Wagener, Colette N Chaney, RN, Kieu-Thu Bui, RN, Shelly Heimfeld, PhD, Philip D. Greenberg, MD

Blood (2014) 124 (21): 3939.

https://doi.org/10.1182/blood.V124.21.3939.3939

Published: 2014

Journal Articles

Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation

Merav Bar, MD, Weigang Tong, Megan Othus, PhD, Keith R Loeb, MD PhD, Elihu H. Estey, MD

Blood (2014) 124 (21): 3941.

https://doi.org/10.1182/blood.V124.21.3941.3941

Published: 2014

Journal Articles

Central Nervous System Relapse In Adults With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Amir Hamdi, MD, Raya Mawad, MD, Antonio Di Stasi, MD, Roland Bassett, MS, Roberto Ferro, MD, Ron Ram, MD, Gabriela Rondon, MD, Richard E Champlin, MD, Brenda M. Sandmaier, MD, Kristine C. Doney, MD, Merav Bar, MD, Partow Kebriaei, MD

Blood (2013) 122 (21): 3311.

https://doi.org/10.1182/blood.V122.21.3311.3311

Published: 2013

NARROW

AI-Generated Synthetic Patient Data Helps in Evaluating Daratumumab Treatment Benefit in Multiple Myeloma Subgroups

HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantation

Large-Scale Post-Transplant TCR Deep Sequencing Reveals a Major T Cell Diversity Bottleneck with Post-Transplant Cyclophosphamide with Implications for Both Efficacy and Toxicity: Results of the BMT CTN 1801 Study

Neutrophil Activation Is a Diagnostic and Candidate Prognostic Biomarker of Acute GvHD

MI-Immune/1801: Lessons from an Ongoing, Multi-Center Trial Involving Biospecimen Collection for Prospective Microbiome and Immune Profiling in Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies

Patient-Reported Outcomes at Time of CAR-T Cell Therapy

Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8 + and CD4 + Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in Progress

Pre-Transplant Gene Expression May Predict Risk of Graft Versus Host Disease

Third Generation CD20 Targeted CAR T-Cell Therapy (MB-106) for Treatment of Patients with Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Mapping the Road of Gvhd and GVT: A Longitudinal Study of Immune-Transcriptome Signatures As Novel Approach to Solve Post-Allogeneic Hematopoietic Cell Transplantation Dilemmas

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor (CAR)-T Cell Therapy

Severe Cytokine Release Syndrome Is Associated with Impaired Hematopoietic Recovery after CD19-Targeted CAR-T Cell Therapy

Late Effects of CD19-Targeted CAR-T Cell Therapy

EBV-Specific Donor Cells Transduced to Express a High-Affinity WT1 TCR Can Prevent Recurrence in Post-HCT Patients with High-Risk AML

Monitoring of Minimal Residual Disease before and after Allogeneic Stem Cell Transplantation Childhood ALL - a Retrospective Assessment on Behalf of the PDWP of the EBMT, the COG, PBMTC, the I-BFM and the Westhafen-Intercontinental-Group

Reversal of Low Donor Chimerism Following Hematopoietic Cell Transplantation Using Pentostatin and Donor Lymphocyte Infusion

Transferred Donor-Derived Virus Specific CD8+ T Cells That Have Been Transduced to Express a WT1-Specific T Cell Receptor Can Persist and Provide Anti-Leukemic Activity in AML Patients Post-Transplant

Central Nervous System Involvement in Acute Myeloid Leukemia Patients Undergoing Hematopoietic Cell Transplantation

Central Nervous System Relapse In Adults With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only